Low-Dose Captopril for the Treatment of Mild to Moderate Hypertension

Digital Record

Identifier: 101584929X98

Staff Only

Digital Object (text)

Go to file

Dates

Publication: [September-October 1983]

Extent

6 pages

Description

In this article, the Veterans Administration Cooperative Study Group reported on their double-blind trial involving the new antihypertensive agent, captopril, an angiotensin converting enzyme (ACE) inhibitor. Like all ACEs, captopril prevents the synthesis of angiotensin II, a hormone that usually causes blood vessels to constrict. Although acknowledging the need for further study, the group determined that captopril appeared to be a very effective antihypertensive agent, especially when administered in combination with the diuretic hydrochlorothiazide.

Language of Materials

English

Additional Description

Original Profiles System Identifier

XFBBGS

Source Category

Periodical

Veterans Administration Cooperative Study Group on Antihypertensive Agents. "Low-Dose Captopril for the Treatment of Mild to Moderate Hypertension." Hypertension (Supp. III) 5, 5 ([September-October 1983]): III-139-III-144. Article. 6 Images.

Hypertension